ASML or AAOI: Which Tech Stock Is Better-Placed at Present?

Zacks frames AI-driven infrastructure demand as a tailwind for ASML and Applied Optoelectronics (AAOI), with ASML positioned as the relative winner. ASML’s 2026 revenue and EPS estimates imply +35.2% and +56% YoY growth, respectively, alongside upward EPS estimate revisions, while AAOI’s 2026 revenue growth is implied at +128% but with recent downward earnings revisions and profitability pressure tied to vertical integration and U.S. capacity builds. On valuation, AAOI trades at 43.21x forward earnings versus ASML at 32.18x, and ASML has outperformed over the last 3 months (high-single-digit gains vs. AAOI’s double-digit decline), suggesting modestly positive relative outlook for ASML.

Analysis

The market is likely underestimating how differently these two names monetize the same AI theme. ASML is the higher-quality expression because its demand is tied to long-cycle, must-have capex and its earnings power is less dependent on a single product ramp or inventory execution; that supports multiple durability even if AI spend normalizes. AAOI has more operating torque, but the combination of heavy fixed-cost absorption, inventory build, and downward estimate momentum makes it more vulnerable to any delay in 800G/next-wave ordering.

Near term, the key separator is revisions, not headline growth rates. If AI infrastructure spending pauses for even one quarter, AAOI’s revenue elasticity cuts both ways, while ASML can still defend profitability through mix, pricing, and backlog visibility. The second-order winner from a customer perspective is probably the broader optical supply chain: any share loss or delivery slippage at AAOI could redirect demand to better-capitalized peers with tighter execution, while also reinforcing the premium for ASML-like scarcity assets.

Contrarian take: the consensus may be too quick to classify both as the same AI trade. They are not—ASML is a semi-monopoly with structural scarcity value, while AAOI is a cyclical component supplier whose valuation already discounts a lot of growth but not enough execution risk. Over 6-18 months, AAOI can outperform only if it converts volume into gross margin expansion and turns revisions positive; absent that, the stock is likely a candidate for multiple compression even if the top line stays strong.

Key Decisions for Investors

• Long ASML / short AAOI as a 1-3 month relative-value pair: express the view that quality, revision momentum, and valuation should continue to separate; target 15-25% relative outperformance for ASML, exit if AAOI estimate revisions turn positive for two consecutive cycles.
• Buy ASML on any AI-semis pullback rather than chasing strength: best risk/reward is on weakness because the franchise quality supports a premium multiple; stop if bookings/order commentary clearly deteriorates over the next earnings cycle.
• Initiate a 3-6 month AAOI put spread or small outright short: the setup is vulnerable to margin disappointment and inventory digestion; thesis is invalidated if gross margin expands faster than revenue and management guides to sustained capacity utilization gains.
• Use SOXX/SMH as a hedge if adding ASML: the trade is cleaner when paired against broad semi beta, since ASML’s idiosyncratic moat is stronger than the sector and should outperform on any AI capex wobble.